Author
Sravani is a proficient Business Analyst with an MBA and a background in Computer Science, with seven years of expe.....
Vitamin B12 Market: By Form, By Grade, By Distribution Channel, By End-Use, and Geography
Vitamin B12 (Cobalamin) Market is estimated to be valued at US$ 311.7 million in 2023 and is poised to grow at a significant CAGR of 8.2% over 2024-2030. Vitamin B12 supplement, B12 supplement for vegans, vitamin B12 naturally, vitamin B12 deficiency, vitamin B12 benefits, methylcobalamin B12, adenosylcobalamin, vitamin B12 foods, vitamin B12 overdose, methylcobalamin dosage for neuropathy, and hydroxocobalamin, to name a few, are highly demanded topics and factors that have influenced market growth in a variety of ways. Leading and emerging market companies investing heavily in research and development in such corresponding factors have seen tremendous business growth. The demand for cyanocobalamin is increasing in the global cyanocobalamin market, particularly among vegans and patients with anemia.
In the food and beverage, nutraceutical, and dietary supplement industries, cyanocobalamin demand is expanding at a rapid rate. In addition, the pharmaceutical industry is seeing an increase in demand for cyanocobalamin. Veganism is gaining popularity among the general public, and many businesses now provide certified vegan food products in their product lines. Food manufacturers have a lot of options to add cyanocobalamin to their goods to meet the demand for B12 among the vegan population, because fortified foods are becoming increasingly popular. In 2017, France and Germany had the greatest percentage of polled individuals aged 16 to 24. Growing environmental concerns, as well as greenhouse gas emissions, are predicted to drive market demand.
Study Period
2024-30Base Year
2023CAGR
8.2%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The increased incidence of hospital-acquired infection is a significant driver of the sterile disposables medical instruments market. Catheter-associated urinary tract infections, central line-associated bloodstream infections, surgical site infections, ventilator-associated pneumonia, hospital-acquired pneumonia, and Clostridium difficile infections are all illnesses that occur while receiving medical care in a hospital. As a result, demand for sterile disposable medical devices such as prefilled syringes, hypodermic needles, and others is increasing, boosting medical device market research. Hospital-acquired viral, bacterial, and fungal diseases impact 14% of all hospital patients, according to the World Health Organization (WHO). As a result, the sterile disposable medical instruments Market is expected to grow faster in the forecast period. However, rising environmental concerns are hampering the market.
Report Benchmarks |
Details |
Report Study Period |
2024-30 |
Market Size in 2023 |
US$ 311.7 million |
Market CAGR |
8.2% |
By Form |
|
By Distribution Channel |
|
By Application |
|
By Grade |
|
Download Free Sample Report
The vitamin b12 (cobalamin) market is projected to expand at a CAGR of 8.2% during the forecast period
Charkit Chemical Company LLC, Apotheca Inc., Mylan N.V., Koninklijke DSM N.V., Chemkart, Merck KGaA, American Regent, Inc.
europe is the fastest-growing region for vitamin b12 (cobalamin) market
1.Executive Summary |
2.Global Vitamin B12 Cobalamin Market Introduction |
2.1.Global Vitamin B12 Cobalamin Market - Taxonomy |
2.2.Global Vitamin B12 Cobalamin Market - Definitions |
2.2.1.Form |
2.2.2.Distribution Channel |
2.2.3.Application |
2.2.4.Grade |
2.2.5.Region |
3.Global Vitamin B12 Cobalamin Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Vitamin B12 Cobalamin Market Analysis, 2019 -2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Vitamin B12 Cobalamin Market By Form, 2019 -2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Powder |
5.1.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Liquid |
5.2.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Capsule |
5.3.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Tablets |
5.4.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Vitamin B12 Cobalamin Market By Distribution Channel, 2019 -2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Online Retails |
6.1.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Offline Retails |
6.2.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Vitamin B12 Cobalamin Market By Application , 2019 -2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Food Industry |
7.1.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Nutraceuticals |
7.2.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Pharmaceutical |
7.3.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Dietary Supplements |
7.4.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Vitamin B12 Cobalamin Market By Grade, 2019 -2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. FoodGrade, |
8.1.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Pharmaceutical Grade |
8.2.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9.Global Vitamin B12 Cobalamin Market By Region, 2019 -2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 -2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Vitamin B12 Cobalamin Market ,2019 -2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Form Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Powder |
10.1.2.Liquid |
10.1.3.Capsule |
10.1.4.Tablets |
10.2. Distribution Channel Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Online Retails |
10.2.2.Offline Retails |
10.3. Application Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Food Industry |
10.3.2.Nutraceuticals |
10.3.3.Pharmaceutical |
10.3.4.Dietary Supplements |
10.4. Grade Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.FoodGrade, |
10.4.2.Pharmaceutical Grade |
10.5. Country Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Vitamin B12 Cobalamin Market ,2019 -2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Powder |
11.1.2.Liquid |
11.1.3.Capsule |
11.1.4.Tablets |
11.2. Distribution Channel Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Online Retails |
11.2.2.Offline Retails |
11.3. Application Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Food Industry |
11.3.2.Nutraceuticals |
11.3.3.Pharmaceutical |
11.3.4.Dietary Supplements |
11.4. Grade Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.FoodGrade, |
11.4.2.Pharmaceutical Grade |
11.5. Country Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
12.Asia Pacific (APAC) Vitamin B12 Cobalamin Market ,2019 -2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Powder |
12.1.2.Liquid |
12.1.3.Capsule |
12.1.4.Tablets |
12.2. Distribution Channel Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Online Retails |
12.2.2.Offline Retails |
12.3. Application Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Food Industry |
12.3.2.Nutraceuticals |
12.3.3.Pharmaceutical |
12.3.4.Dietary Supplements |
12.4. Grade Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.FoodGrade, |
12.4.2.Pharmaceutical Grade |
12.5. Country Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Vitamin B12 Cobalamin Market ,2019 -2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Powder |
13.1.2.Liquid |
13.1.3.Capsule |
13.1.4.Tablets |
13.2. Distribution Channel Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Online Retails |
13.2.2.Offline Retails |
13.3. Application Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Food Industry |
13.3.2.Nutraceuticals |
13.3.3.Pharmaceutical |
13.3.4.Dietary Supplements |
13.4. Grade Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.FoodGrade, |
13.4.2.Pharmaceutical Grade |
13.5. Country Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Vitamin B12 Cobalamin Market ,2019 -2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Form Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Powder |
14.1.2.Liquid |
14.1.3.Capsule |
14.1.4.Tablets |
14.2. Distribution Channel Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Online Retails |
14.2.2.Offline Retails |
14.3. Application Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Food Industry |
14.3.2.Nutraceuticals |
14.3.3.Pharmaceutical |
14.3.4.Dietary Supplements |
14.4. Grade Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.FoodGrade, |
14.4.2.Pharmaceutical Grade |
14.5. Country Analysis 2019 -2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Charkit Chemical Company LLC |
15.2.2.Apotheca Inc. |
15.2.3.Mylan N.V. |
15.2.4.Koninklijke DSM N.V. |
15.2.5.Chemkart |
15.2.6.Merck KGaA |
15.2.7.American Regent, Inc. |
15.2.8.Johnlee Pharmaceuticals Pvt. Ltd. |
15.2.9.Interaction Pharmaceuticals Private Limited |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players